Marksans Pharma Peer Comparison

Marksans Pharma Ltd. presents a balanced financial profile with solid growth metrics and healthy profitability ratios, positioning it as a strong contender in the Pharmaceuticals & Drugs sector. It outperforms several peers in key financial metrics while maintaining a lower debt level, making it an attractive option for investors looking for stability and growth.

• • Marksans Pharma shows strong revenue growth and reasonable EPS growth compared to peers.
• • It maintains a low debt equity ratio, indicating low financial risk.
• • The company has competitive profitability margins, particularly in the pharmaceutical sector.

• • Dr. Reddy's Laboratories Ltd.: Highest ROE, ROA, and ROCE, alongside solid profitability metrics.
• • Cipla Ltd.: Strong profitability with the lowest PE ratio, indicating potential undervaluation.
• • Mankind Pharma Ltd.: High revenue growth and EPS growth rates, indicating rapid expansion.